Current primary open-angle glaucoma treatments and future directions.
about
Efficacy and tolerability of mono-compound topical treatments for reduction of intraocular pressure in patients with primary open angle glaucoma or ocular hypertension: an overview of reviews.Evidence of BrdU-positive retinal neurons after application of an Alpha7 nicotinic acetylcholine receptor agonist.Bimatoprost 0.01% in treatment-naïve patients with open-angle glaucoma or ocular hypertension: an observational study in the Korean clinical settingEfficacy and tolerability of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure: a meta-analysis of randomized controlled trials.Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapyRetinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors.Building a glaucoma interaction network using a text mining approach.Inter-device reproducibility of retrobulbar blood flow velocity measurements in healthy subjects using color Doppler imaging.New therapeutic targets for intraocular pressure lowering.Glaucomatous optic neuropathy management: the role of neuroprotective agents.Present and New Treatment Strategies in the Management of Glaucoma.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.Characterizing the "POAGome": A bioinformatics-driven approach to primary open-angle glaucoma.Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation.
P2860
Q34492862-4E8C3954-6652-484C-B794-D5F98D430168Q34550442-208E7CAD-7F60-4978-B685-8C8336DC8EE2Q34901153-171BC453-2CEF-4B5D-A209-E23F2D58AE9FQ35071041-8EBE2752-D98B-4DBA-BADB-9A2195CE2D4AQ35596464-108B1156-C96B-46EF-8055-1E493498171FQ35736555-7C273FF3-D149-41C7-8F44-082DBBB71849Q36871674-31C239BD-7DEA-4155-8FE4-4A8648DBDCE8Q36932438-6085FA96-B889-478E-915F-097C24298C7AQ38190064-92281713-2A8F-488D-9FB2-F35F9EE7FE90Q38193827-A7F34531-5289-43A5-887D-6C1B81FD317FQ38526185-C3D600CB-C7C6-4C87-AB55-03CA36A3E5A5Q38584194-8BF12E8B-DDA7-4630-9547-E49E15BDC8F3Q39145730-7BE8D5B3-25DC-4F80-B1ED-41FA37F672E9Q52143379-7E0FA606-104E-4885-96EF-E84FF66D9F9D
P2860
Current primary open-angle glaucoma treatments and future directions.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Current primary open-angle glaucoma treatments and future directions.
@ast
Current primary open-angle glaucoma treatments and future directions.
@en
type
label
Current primary open-angle glaucoma treatments and future directions.
@ast
Current primary open-angle glaucoma treatments and future directions.
@en
prefLabel
Current primary open-angle glaucoma treatments and future directions.
@ast
Current primary open-angle glaucoma treatments and future directions.
@en
P2860
P356
P1476
Current primary open-angle glaucoma treatments and future directions
@en
P2093
Gabriel Beidoe
P2860
P304
P356
10.2147/OPTH.S32933
P407
P577
2012-10-23T00:00:00Z